Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-27

Clinical Trial Update: Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy [NA]

View source ↗

Summary

Clinical trial update evaluating fluoxetine for reducing ictal hypoventilation in patients with uncontrolled partial epilepsy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: University of California, Davis | Conditions: Uncontrolled Partial Epilepsy, Ictal Hypoventilation | NA | Status: COMPLETED | Results posted: 2019-11-27